Clarus Lifesciences III L.P. 13D and 13G filings for Entasis Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-09 4:48 pm Sale | 2020-07-02 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Clarus Lifesciences III L.P. | 1,339,836 4.900% | -283,569 (-17.47%) | Filing |
| 2020-05-01 5:01 pm Unchanged | 2019-04-22 | 13D | Entasis Therapeutics Holdings Inc. ETTX | Clarus Lifesciences III L.P. | 1,623,405 11.100% | 0 (Unchanged) | Filing |